A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach

F Andreu; H Colom; Laure Elens; Teun Gelder; Ron van Schaik; Dennis Hesselink; O Bestard; J Torras; JM Cruzado; JM Grinyo; N Lloberas

doi:10.1007/s40262-016-0491-3

A New CYP3A53 and CYP3A422 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach

F Andreu, H Colom, Laure Elens, Teun Gelder, Ron van Schaik, Dennis Hesselink, O Bestard, J Torras, JM Cruzado, JM Grinyo, N Lloberas

Research output: Contribution to journal › Article › Academic › peer-review

89 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	963-975
Number of pages	13
Journal	Clinical Pharmacokinetics
Volume	56
Issue number	8
DOIs	https://doi.org/10.1007/s40262-016-0491-3
Publication status	Published - 2017

Research programs

EMC MM-01-25-01

Access to Document

10.1007/s40262-016-0491-3

http://hdl.handle.net/1765/95286

Cite this

@article{e0a2b4a526a24600a16b0fc9d965e2d2,

title = "A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach",

author = "F Andreu and H Colom and Laure Elens and Teun Gelder and \{van Schaik\}, Ron and Dennis Hesselink and O Bestard and J Torras and JM Cruzado and JM Grinyo and N Lloberas",

year = "2017",

doi = "10.1007/s40262-016-0491-3",

language = "Undefined/Unknown",

volume = "56",

pages = "963--975",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "8",

}

TY - JOUR

T1 - A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach

AU - Andreu, F

AU - Colom, H

AU - Elens, Laure

AU - Gelder, Teun

AU - van Schaik, Ron

AU - Hesselink, Dennis

AU - Bestard, O

AU - Torras, J

AU - Cruzado, JM

AU - Grinyo, JM

AU - Lloberas, N

PY - 2017

Y1 - 2017

U2 - 10.1007/s40262-016-0491-3

DO - 10.1007/s40262-016-0491-3

M3 - Article

C2 - 28050888

SN - 0312-5963

VL - 56

SP - 963

EP - 975

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 8

ER -